CKD-828 (80/5mg) Pharmacokinetic Study

Not yet recruiting No Results Available Drug: CKD‐828|Drug: Telmisartan|Drug: S‐amlodipine Male Adult Phase 1 68 Interventional Allocation: Randomized|Endpoint Classification: Pharmacokinetics Study|Intervention Model: Crossover Assignment|Primary Purpose: Treatment|Masking: Open Label Cmax after administration of CKD‐828(Fixed Dose Combination) tablet and coadministration of corresponding dose of telmisartan and s‐amlodipine.|AUClast after administration of CKD‐828(Fixed Dose Combination) tablet and coadministration of corresponding dose of telmisartan and s‐amlodipine.|Tmax after administration of CKD‐828(Fixed Dose Combination) tablet and coadministration of corresponding dose of telmisartan and s‐amlodipine.|t1/2 after administration of CKD‐828(Fixed Dose Combination) tablet and coadministration of corresponding dose of telmisartan and s‐amlodipine.|AUCinf after administration of CKD‐828(Fixed Dose Combination) tablet and coadministration of corresponding dose of telmisartan and s‐amlodipine.|Number of participants with adverse events